AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer.

With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensi...

Wall Street kicked off the new week on a flat note after the worst weekly slump for tech stocks since April, as investors remai...

A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed t...

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.

Investors stepped back into beaten-down tech names Friday, with the Nasdaq 100 rising 0.6% by midday in New York, staging a mod...

After the U.S. shutdown ends, markets fall as investors shift from QQQ, SPY and DIA, to defensive ETFs amid renewed caution.